Skip to Main Content

Paper Details

An approach to suppress the evolution of resistance in BRAF<sup>V600E</sup>-mutant cancer.
Nat Med
120
2017
BRAF, BRAF oncogene, BRAFV600E, BRAFV600E-mutant cancer, BRAFamp, ERK, ERK kinases, MEK, PDXs, RAF, extra, lung cancer, melanoma, mice, patient, patient-derived, patients, subclonal populations, subclones, tumor, tumors
Author NameAffiliation
Luciano G MartelottoMemorial Sloan Kettering Cancer Center
Gregory J RielyMemorial Sloan Kettering Cancer Center
Elisa de StanchinaMemorial Sloan Kettering Cancer Center
Michael F BergerMemorial Sloan Kettering Cancer Center
Michael F BergerWeill Cornell Medical College, Cornell University
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
  • 1 - 6

Datasets

Release 1.2